Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemiaSurvival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia, Published online: 22 August 2018; doi:10.1038/s41408-018-0117-0Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Source: Blood Cancer Journal - Category: Hematology Authors: Lia Gore Franco Locatelli Gerhard Zugmaier Rupert Handgretinger Maureen M. O ’Brien Peter Bader Deepa Bhojwani Paul-Gerhardt Schlegel Catherine A. Tuglus Arend von Stackelberg Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer | Cancer & Oncology | Hematology | Leukemia | Pediatrics